Found 242 articles for: "basal cell carcinoma"
Antidiabetic Treatment in Patients at High Risk for a Subsequent Keratinocyte Carcinoma
May 2022 | Volume 21 | Issue 5 | Original Article | 502 | Copyright © May 2022
Background: Metformin and sulfonylureas are the most commonly prescribed drugs used for the treatment of type II diabetes. Type II diabetes has been linked to the development of kerat...
Read MoreGiant Basal Cell Carcinoma of the Axilla: 8-year Follow-up of a Case Treated with Excision, Vismodegib, and Radiotherapy
May 2022 | Volume 21 | Issue 5 | Case Reports | 531 | Copyright © May 2022
Axillary giant basal cell carcinoma is extremely rare and remains challenging for physicians. The few reported cases have a relatively short-term follow-up, and none were treated with an oral hedgehog...
Read MoreConsistency in Distribution of Facial Skin Cancers Treated With Mohs Micrographic Surgery
May 2022 | Volume 21 | Issue 5 | Original Article | 506 | Copyright © May 2022
Mohs micrographic surgery (MMS) has become the standard of treatment for skin malignancies of the head and neck. However, there is a paucity of literature describing facial distributions of MMS. Anato...
Read More2020 IDEOM Annual Meeting: Actinic Keratosis Stakeholders Survey Identifies Gaps in Research and Care
February 2022 | Volume 21 | Issue 2 | Original Article | 128 | Copyright © February 2022
This is a report of the survey results from the International Dermatology Outcome Measures (IDEOM) actinic keratosis (AK) workgroup. The purpose of the survey was to compile a list of gaps within AK c...
Read MoreArtificial Intelligence in the Evaluation of Telemedicine Dermatology Patients
February 2022 | Volume 21 | Issue 2 | Original Article | 191 | Copyright © February 2022
Background: Background: Early detection of malignant skin lesions reduces morbidity. There is increased need for a telemedicine triage tool to prioritize patients who require in-perso...
Read MoreUse of Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis: A Systematic Review
January 2022 | Volume 21 | Issue 1 | Original Article | 60 | Copyright © January 2022
Background: Actinic Keratosis (AK) is a premalignant lesion that can progress to cutaneous squamous cell carcinoma (cSCC). Topical 5-Fluorouracil (5-FU) and imiquimod have been used f...
Read MoreUnna Boot With Keystone Advancement Flap Leads to Excellent Outcomes for Lower Extremity Reconstruction
December 2021 | Volume 20 | Issue 12 | Original Article | 1308 | Copyright © December 2021
Background: The reconstruction of lower extremity defects can be technically challenging. The keystone island perforator flap is a workhorse reconstructive option for difficult-to-rep...
Read MoreAminolevulinic Acid 20% Solution Combined With Photodynamic Therapy for Treatment of Actinic Keratoses: A Review
November 2021 | Volume 20 | Issue 11 | Original Article | 1239 | Copyright © November 2021
Actinic keratoses (AK) are lesions with potential to transform into nonmelanoma skin cancers. Numerous methods are available for treatment of AK. Here, we review clinical trial data on the use of phot...
Read MoreINDIVIDUAL ARTICLE: Safety and Tolerability of Topical Agents for Actinic Keratosis: A Systematic Review of Phase 3 Clinical Trials
October 2021 | Volume 20 | Issue 10 | Supplement Individual Articles | s4s4 | Copyright © October 2021
Background: Topical agents for actinic keratosis (AK), along with cryotherapy and phototherapy, are the most commonly used therapies for areas of skin with multiple AKs. Multiple opti...
Read MoreCharacteristics of Superficial Basal Cell Carcinomas Containing More Aggressive Subtypes on Final Histopathologic Diagnosis
August 2021 | Volume 20 | Issue 8 | Original Article | 874 | Copyright © August 2021
Background: The prognosis and treatment of basal cell carcinoma (BCC) are largely dependent on tumor subtype, which is typically determined by punch or shave biopsy. Data regarding co...
Read MoreCombining Panitumumab With Anti-PD-1 Antibody in Cutaneous Squamous Cell Carcinoma of the Head and Neck After Inadequate Response to Anti-PD-1 Antibody Alone
August 2021 | Volume 20 | Issue 8 | Case Reports | 901 | Copyright © August 2021
Anti-epidermal growth factor receptor (EGFR) antibodies and anti-programmed cell death 1 protein (PD-1) antibodies have been used separately to treat metastatic cutaneous squamous cell carcinoma (cSCC...
Read MoreIdentifying Areas for Improvement in Remote Skin Cancer Management: Surveillance, Diagnostics, and Skin of Color
July 2021 | Volume 20 | Issue 7 | Features | 792 | Copyright © July 2021
Skin of Color Representation in Commonly Utilized Medical Student Dermatology Resources
July 2021 | Volume 20 | Issue 7 | Editorials | 799 | Copyright © July 2021
Basal Cell Carcinoma Gene Mutations Differ Between Asian, Hispanic, and Caucasian Patients: A Pilot Study
May 2021 | Volume 20 | Issue 5 | Original Article | 504 | Copyright © May 2021
Background: Basal cell carcinoma (BCC) is the most common malignancy worldwide. While most BCCs are treated surgically, adv...
Read MoreBilateral Contiguous Scrotal Extramammary Paget's Disease Treated With Mohs Micrographic Surgery and CK7 Immunohistochemical Staining
May 2021 | Volume 20 | Issue 5 | Features | 565 | Copyright © May 2021
Extramammary Paget’s Disease (EMPD) is a rare malignancy that commonly presents on apocrine-rich skin as a unilateral scaly patch or plaque ...
Read MoreNovel Treatment of In-Transit Metastatic Melanoma With Shave Excision, Electrodesiccation and Curettage, and Topical Imiquimod 5% Cream
May 2021 | Volume 20 | Issue 5 | Case Reports | 555 | Copyright © May 2021
In-transit metastatic melanoma is classified as a regional intralymphatic metastasis of melanoma. Currently, there is no standardized regimen used to treat in-transit metastatic melanoma, and therapy ...
Read MoreVismodegib as Eye-Sparing Neoadjuvant Treatment for Locally Advanced Periocular Basal Cell Carcinoma
May 2021 | Volume 20 | Issue 5 | Case Reports | 552 | Copyright © May 2021
Locally-advanced periocular basal cell carcinoma (BCC) pose many therapeutic challenges due to the need to preserve functionality and cosmesis of the orbit and periocular area. Surgical excision and s...
Read MoreARTICLE: Recent Advances in Skin Barrier Research: From Basic Science to Clinical Discovery
April 2021 | Volume 20 | Issue 4 | Supplement Individual Articles | s2 | Copyright © April 2021
Mohs Micrographic Surgery for Genital Skin Cancer: A Review of Cases and Reconstructive Techniques
March 2021 | Volume 20 | Issue 3 | Original Article | 311 | Copyright © March 2021
As the incidence of non-melanoma skin cancer (NMSC) increases in the United States, one area of particular concern is NMSC arising on the genitalia. In the past, most genital skin tumors have been tre...
Read MoreA Non-Surgical and Cost-Effective Treatment Approach Employing Topical Imiquimod, 5-Fluorouracil, and Tretinoin for Primary Non-Melanoma Skin Cancers
March 2021 | Volume 20 | Issue 3 | Original Article | 260 | Copyright © March 2021
Background: Minimally invasive alternative approaches to treat non-melanoma skin cancers remain limited and unproven.
Objective: We aim to assess the efficacy o...
Read More